Three Weeks in Florida

Update Item Information
Identifier walsh_2015_s2_c2
Title Three Weeks in Florida
Creator Andrew R. Carey; J. Antonio Bermudez-Magner; Sander R. Dubovy; Norman J. Schatz; Linda L. Sternau; Byron L. Lam
Affiliation (ARC) (JAB) (SRB) (NJS) (BLL) Bascom Palmer Eye Institute / University of Miami / Miller School of Medicine / Department of Ophthalmology Miami, FL; (LLS) Memorial Regional Hospital / Department of Neurosurgery Hollywood, FL
Subject Papilledema, Leptomeningeal Melanomatosis, Vision Loss, Headache, Magnetic Resonance Imaging
Description The patient underwent leptomeningeal biopsy. During surgery, the meninges were noted to have diffuse pigmentation. Histopathologic evaluation demonstrated proliferation of heavily pigmented cells with prominent nucleoli. Immunostains were diffusely positive for S-100 as well as melanocytic markers HMB-45, MART-1 and tyrosinase while negative for keratinocyte markers AE1/AE3, and PCK26. The Ki-67 staining showed foci of elevated labeling > 10%. Genetic testing was negative for BRAF p.V600E and BRAF p.V600K mutations. Full body dermatologic examination was negative for pigmented skin lesions. CT of the chest, abdomen, and pelvis were negative for tumors. PET scan was unattainable while inpatient. Ophthalmic examination demonstrated the patient was awake but confused and only partially aware of his surroundings. Visual acuity was 20/400 in each eye, visual fields were constricted to confrontation by finger counting. His extraocular movements appeared to be full with some exotropia. His pupils were noted to be sluggish and mid-dilated but no afferent defects were present. His anterior segment was unremarkable without scleral pigmentation; fundus examination was significant for grade 3 papilledema without any tumors present. He then underwent ventriculo-peritoneal shunt placement for persistent hydrocephalus. He was started on ipilimumab, a monoclonal antibody to increase immune response to melanoma cells. The patient was discharged to rehab where he self-extubated his tracheostomy and could not be re-intubated subsequently expiring. Autopsy was not feasible as death notification occurred over 36 hours.
History A 36 year-old man presented with severe headaches, bilateral leg numbness, and bilateral decreased vision. He was born in Ecuador where he received BCG vaccination and immigrated to US at age 19. In 2005 he enrolled in nursing school and volunteered in homeless shelters. PPD was positive with a negative chest x-ray. In August 2011 he developed pleuritic chest pain; chest x-ray showed a 2 cm cavitary lesion in the right upper lobe. He was diagnosed with active TB and completed treatment in August 2013. In December 2013 he developed headaches associated with neck stiffness and intermittent blurry vision which progressed over 6 months. In May 2014, while on vacation in Ecuador, he had a prolonged seizure requiring intubation. Upon recovery he returned to Florida and presented to the emergency department with visual loss and drowsiness, but arousable to verbal stimuli. Vision was light perception OU with sluggish pupils. Extraocular movements were full but demonstrated exotropia. Fundus examination showed papilledema. Strength was reduced in all four limbs with apraxia in the upper right. Sensation was decreased from groin to foot, left worse than right. Serum white count was elevated to 25,300. Brain MRI demonstrated hydrocephalus and diffuse leptomeningeal enhancement including bilateral intracranial optic nerves and chiasm. CSF analysis showed 110 leukocytes with 66% monocytes. Lumbar spine MRI was negative. The patient was diagnosed with recurrent TB with meningitis and was restarted on TB medications. CSF smears, cultures, and PCR were negative for infection including TB. Lumbar drain was placed and ICP was 40 cm water. Repeat brain MRI showed progressive leptomeningeal enhancement and hydrocephalus. Repeat CSF analysis demonstrated cellular atypia with equivocal immuno-histochemical staining. Flow cytometry revealed a mixture of immune cells but no B lymphocytes. A diagnostic procedure was performed.
Disease/Diagnosis Primary Leptomeningeal Melanomatosis
Date 2015-02
References 1. Arias M 1 , Alberte-Woodward M, Arias S et al. Primary malignant meningeal melanomatosis: a clinical, radiological and pathologic case study. Acta Neurol Belg. 2011 Sep;111(3):228-31. 2. Bot I, Blank CU, Brandsma D. Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab. J Neurol (2012) 259:1976-1978 3. Burrows AM 1 , Smith TW, Hall WR, Pilitsis JG. Neurological picture. Ascending paralysis from malignant leptomeningeal melanomatosis. J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):449-50 4. Harstad L 1 , Hess KR, Groves MD. Prognostic factors and outcomes in patients with leptomeningeal melanomatosis. Neuro Oncol. 2008 Dec;10(6):1010-8. 5. Hsieh YY 1 , Yang ST, Li WH, Hu CJ, Wang LS. Primary Leptomeningeal Melanoma Mimicking Meningitis: A Case Report and Literature Review. J Clin Oncol. 2014 Mar 17
Language eng
Format video/mp4
Type Image/MovingImage
Source 47th Annual Frank Walsh Society Meeting
Relation is Part of NANOS Annual Meeting 2015
Collection Neuro-Ophthalmology Virtual Education Library: Walsh Session Annual Meeting Archives: https://novel.utah.edu/Walsh/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2015. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6bp30fg
Setname ehsl_novel_fbw
ID 179280
Reference URL https://collections.lib.utah.edu/ark:/87278/s6bp30fg
Back to Search Results